Cytodyn Inc

CytoDyn Inc. is a biotechnology company focused on developing innovative HIV treatments with a global reach and a market capitalization of approximately $389.45 million.

CytoDyn Inc. is a biotech company making significant strides in the fight against HIV, despite financial turbulence, with a commitment to innovation and global health.